Mozobil
- Product NDC
- 0024-5862
- 11-digit product format
- 000245862
- Labeler code
- 0024
- Product ID
- 0024-5862_fec4102e-2c66-433f-ab6c-7f420b4c3a86
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PLERIXAFOR
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Sanofi-Aventis U.S. LLC
- Application
- NDA022311
- Marketing category
- NDA
- Marketing start
- 2013-09-01
- Substance
- PLERIXAFOR
- Active strength
- 24 mg/1.2mL
- Pharmacologic classes
- Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Mozobil
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PLERIXAFOR | 24 mg/1.2mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | S915P5499N |
| Rxcui | 828700, 828703 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0024-5862-01 | Mozobil | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 24 |
| 0024-5862-01 | Mozobil | 1.2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 1.2 | | 24 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0024-5862 | MOZOBIL (PLERIXAFOR) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 23 | Current NDC, Legacy NDC, 2 package rows | 20231007_0ed08d2b-5051-46b2-aa37-1d6275bf9003.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0024-5862-01 | 00024586201 | 1 VIAL, SINGLE-USE in 1 CARTON (0024-5862-01) / 1.2 mL in 1 VIAL, SINGLE-USE | 2013-09-01 | 0000-00-00 | No | No | Current |